Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests

BACKGROUND: With rapid approval of SARS-CoV-2 vaccines, the ability of clinical laboratories to detect vaccine-induced antibodies with available high-throughput commercial assays is unknown. We aimed to determine if commercial serology assays can detect vaccine-induced antibodies (VIAs) and understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanji, Jamil N., Bailey, Ashley, Fenton, Jayne, Ling, Sean H., Rivera, Rafael, Plitt, Sabrina, Sligl, Wendy I., Taylor, Sean, Turnbull, LeeAnn, Tipples, Graham, Charlton, Carmen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354789/
https://www.ncbi.nlm.nih.gov/pubmed/34454782
http://dx.doi.org/10.1016/j.vaccine.2021.08.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354789/
https://www.ncbi.nlm.nih.gov/pubmed/34454782
http://dx.doi.org/10.1016/j.vaccine.2021.08.022

Ejemplares similares